Rhythm Pharmaceuticals's total assets for Q3 2025 were $506.87M, an increase of 35.99% from the previous quarter. RYTM total liabilities were $358.06M for the fiscal quarter, a -6.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.